Chronic Mouth Breathing and SARS-CoV-2 Positivity in the Pediatric Population
BREATH-COV
Investigation of the Relationship Between Chronic Mouth Breathing and SARS-CoV-2 Positivity in the Pediatric Population
1 other identifier
observational
173
1 country
1
Brief Summary
Numerous non-scientific articles on the internet assert the significance of nasal breathing in protecting against COVID-19. Although nasal breathing is anticipated to result in a reduced intake of bioparticles when compared to mouth breathing due to the filtering mechanisms present in the nasal cavity, we have yet to identify any in vivo studies within the literature that definitively ascertain the correlation between mouth breathing and COVID-19 positivity. Consequently, this study aimed to investigate the impact of chronic mouth breathing on testing positive for COVID-19 in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2022
CompletedFirst Submitted
Initial submission to the registry
June 26, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedJuly 14, 2025
June 1, 2025
3 days
June 26, 2025
July 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of COVID-19 Positivity in Chronic Mouth Breathers Compared to Nasal Breathers
Proportion of COVID-19 positivity among chronic mouth breathers compared to nasal breathers
At 2 weeks post-COVID-19 recovery"
Study Arms (2)
COVID-19 Positive Group
Participants who tested positive for SARS-CoV-2 by PCR at the time of evaluation.
COVID-19 Negative Group
Participants who tested negative for SARS-CoV-2 by PCR at the time of evaluation.
Eligibility Criteria
A total of 173 patients aged between 10 and 17 years, without any systemic diseases or COVID-19 vaccinations, who were undergoing COVID-19 testing, were included in the study.
You may qualify if:
- tested for COVID-19
You may not qualify if:
- Not tested for COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Usak University Faculty of Dentistry
Izmir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Orthodontics
Study Record Dates
First Submitted
June 26, 2025
First Posted
July 14, 2025
Study Start
March 2, 2022
Primary Completion
March 5, 2022
Study Completion
May 2, 2022
Last Updated
July 14, 2025
Record last verified: 2025-06